FindTrial
Sign In

Implantable cardioverter defibrillator as primary prevention of sudden cardiac death in patients with heart failure: A prospective randomized controlled study

Implantable cardioverter defibrillator as primary prevention of sudden cardiac death in patients with heart failure: A prospective randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-16009605
Enrollment
Unknown
Registered
2016-10-26
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden cardiac death

Interventions

ICD Implantation Group:Implantation of ICD
Control group:Without implantation of ICD

Sponsors

Shanghai general hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 20 years; 2. Clear diagnosis of heart failure by clinical examination; 3. After long time of optimal drug therapy, NYHA class II-III, and expected to survive more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Less than 40 days from myocardial infarction occurred; 2. Haved history of cardiac arrest,ventricular fibrillation,ventricular tachycardia with hemodynamic instability; 3. Coronary Revascularization by CABG or PCI within 2 months; 4. Women in childbear age who use contraceptives; 5. Combined with severe cerebrovascular disease; 6. Combined with the situation which increased mortality in patients; 7. Participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Sudden death;—

Countries

China

Contacts

Public ContactFang Wang

Shanghai 1st People's Hospital

onlyfang1@163.com+86 13621950918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026